About

Learn more about our mission and team.

Mission

Our mission is to transform the standard of care for hypertrophic cardiomyopathy and related conditions.

[data-wf-bgvideo-fallback-img] { display: none; } @media (prefers-reduced-motion: reduce) { [data-wf-bgvideo-fallback-img] { position: absolute; z-index: -100; display: inline-block; height: 100%; width: 100%; object-fit: cover; } }

Team

Braveheart’s team represents an accomplished, mission-driven group of people committed to advancing care for patients.

Travis Murdoch, MD

Chief Executive Officer and President

Michele Anderson

Chief Development Officer

Chief Financial Officer

Marc Evanchik, MS

Senior Vice President of Pharmacology and Translational Medicine

Natalie Dement, JD

Vice President, Head of Legal

Vice President of Biometrics and Data Management

Director, Corporate Development

Associate Director of Human Resources & Office Manager

Board of Directors

Chris Viehbacher

Chair of the Board

Jasper Bos, PhD

Board Director

Erez Chimovits, MBA, MSc

Board Director

Jason Coloma, PhD, MBA

Board Director

Tim Lohoff, PhD

Board Director

David Malek, MBA

Board Director

Vineeta Agarwala, MD, PhD

Board Observer

Evan Caplan, MD, MBA

Board Observer

Neel Varshney, MD

Board Observer

Investors

[data-wf-bgvideo-fallback-img] { display: none; } @media (prefers-reduced-motion: reduce) { [data-wf-bgvideo-fallback-img] { position: absolute; z-index: -100; display: inline-block; height: 100%; width: 100%; object-fit: cover; } }

Interested in joining our team?

Reach out to learn more about our openings.